Real World Comparative Effectiveness Data of Natalizumab Vs Fingolimod for the Treatment of Relapsing-Remitting Multiple Sclerosis: Results from a Systematic Literature Review

S. Lang, R. Wolff,P. Annovazzi,D. Baroncini,T. Kalincik,N. Koch-Henriksen,D-A. Laplaud,C. Acosta

MULTIPLE SCLEROSIS JOURNAL（2017）

Cited 0|Views11
No score
Key words
Natalizumab
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined